Laurence Jesel

Laurence Jesel

Auto-generated profile, based on publicly available information

Laurence Jesel

University of Strasbourg, UR 3074, Translational Cardiovascular Medicine, FMTS, Biomedicine Research Center of Strasbourg, Strasbourg, France; Cardiology Department, Strasbourg University Hospital, Strasbourg, France

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2024 in Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
WFWalaa Fakih
Walaa Fakih
AMAli Mroueh
Ali Mroueh
DGDal-Seong Gong
Dal-Seong Gong
SKShinnosuke Kikuchi
Shinnosuke Kikuchi
MPMichael Paul Pieper
Michael Paul Pieper
LJLaurence Jesel
Laurence Jesel
Aims: Atrial fibrillation (AF), the most common cardiac arrhythmia favouring ischemic stroke and heart failure involves left atrial remodelling, fibrosis and a complex interplay between cardiovascular risk factors. This study examined whether activated factor X (FXa) induces pro-remodelling and pro-fibrotic responses in atrial endothelial cells (AECs) and human atrial tissues and determined the underlying mechanisms. Methods and results: AECs collected from porcine hearts and human right atrial appendages (RAA) from patients undergoing heart surgery. Protein expression levels were assessed by Western blot and immunofluorescence staining, mRNA levels by RT-qPCR, formation of reactive oxygen species (ROS) and NO using fluorescent probes, thrombin and angiotensin II generation by specific assays, fibrosis by Sirius red staining and senescence by senescence-associated beta-galactosidase (SA-β-gal) activity. In AECs, FXa increased ROS formation, senescence (SA-β-gal activity, p53, p21), angiotensin II generation and the expression of pro-inflammatory (VCAM-1, MCP-1), pro-thrombotic (tissue factor), pro-fibrotic (TGF-β and collagen-1/3a) and pro-remodelling (MMP-2/9) markers whereas eNOS levels and NO formation were reduced. These effects were prevented by inhibitors of FXa but not thrombin, protease-activated receptors antagonists (PAR-1/2) and inhibitors of NADPH oxidases, ACE, AT1R, SGLT1/SGLT2. FXa also increased expression levels of ACE1, AT1R, SGLT1/2 proteins which were prevented by SGLT1/2 inhibitors. Human RAA showed tissue factor mRNA levels that correlated with markers of endothelial activation, pro-remodelling and pro-fibrotic responses and SGLT1/2 mRNA levels. They also showed protein expression levels of ACE1, AT1R, p22phox, SGLT1/2, and immunofluorescence signals of nitrotyrosine and SGLT1/2 colocalized with those of CD31. FXa increased oxidative stress levels which were prevented by inhibitors of the AT1R/NADPH oxidases/SGLT1/2 pathway. Conclusion: FXa promotes oxidative stress triggering premature endothelial senescence and dysfunction associated with pro-thrombotic, pro-remodelling and pro-fibrotic responses in AECs and human RAA involving the AT1R/NADPH oxidases/SGLT1/2 pro-oxidant pathway. Targeting this pathway may be of interest to prevent atrial remodelling and the progression of atrial fibrillation substrate.

6 June 2026 in JACC: Basic To Translational Science
Verified
Journal Article
Open access
WFWalaa Fakih
Walaa Fakih
AMAli Mroueh
Ali Mroueh
SKShinnosuke Kikuchi
Shinnosuke Kikuchi
HMHalim Marzak
Halim Marzak
SASaid Amissi
Said Amissi
LJLaurence Jesel
Laurence Jesel
• RAA from AF patients show higher inflammation and oxidative stress vs non-AF • RAA inflammation correlates with SGLT2 and GLP-1R expression. • SGLT2 and GLP-1R modulation exert synergistic antioxidant effects in RAA • Combined SGLT2i/GLP-1Ra therapy represents a promising strategy against AF remodeling

11 May 2023 in Archives of Cardiovascular Diseases Supplements
Verified
Journal Article
Closed access
ACAurélien Clédel
Aurélien Clédel
VWVictor Waldmann
Victor Waldmann
CMChristelle Marquié
Christelle Marquié
LKLinda Koutbi
Linda Koutbi
LJLaurence Jesel
Laurence Jesel
JGJean-Baptiste Gourraud
Jean-Baptiste Gourraud